ReWalk Robotics Ltd. RWLK
Jan 29, 2024, 3:59 PM EST
52-week range unavailable
- Market cap
- 63.03M
- Revenue (ttm)
- 9.15M
- Profit margin
- -238.35%
- Shares out
- 8.50M
- Forward P/E
- -2.84
- Volume
- 300.51K
- Open
- 1.01
- Previous close
- 1.05
- Day's range
- 0.98 – 1.10
- Beta
- 2.31
- Analysts
- Buy
- Earnings date
- Feb 22, 2024
3M +0.36 (+52.88%)
Key statistics
- Enterprise value
- 32.54M
- PEG ratio
- 0.00
- Price / sales
- 0.98
- Price / book
- 1.22
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 397.00%
- Free cash flow
- -9.25M
- Total cash
- 32.59M
- Total debt
- 2.10M
- Return on equity
- -34.24%
- Short % of float
- 2.77%
- 50-day average
- 0.883024
- 200-day average
- 0.739605
Analyst view
Consensus: buy
- Strong buy3
- Buy1
- Hold0
- Sell1
- Strong sell0
Next earnings
Feb 22, 2024
Expected Feb 22, 2024. Consensus EPS estimate -0.10.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 22, 2024 | Dec 1, 2023 | -0.13 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -0.11 | — | — | — |
| Aug 11, 2023 | Jun 1, 2023 | -0.07 | — | — | — |
| May 11, 2023 | Mar 1, 2023 | -0.08 | — | — | — |
| Feb 23, 2023 | Dec 1, 2022 | -0.07 | — | — | — |
| Nov 7, 2022 | Sep 1, 2022 | -0.06 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 9, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 2, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Feb 23, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Nov 14, 2022 | HC Wainwright & Co. | main | — | Buy |
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Israel
- Website
- rewalk.com
News
VA STAND Act introduced in the United States Senate 
4 Must-Buy Efficient Stocks to Increase Your Portfolio Returns 
Lifeward Announces Reverse Share Split 
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy 
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered 
ReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue Estimates 
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results 
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward 
7 ‘AgeTech' Stocks to Profit From the Booming Longevity Market
Your note
Sign in to keep a note on RWLK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DAN ARYEH | Director | Sale | Aug 14, 2023 | 0 |
| DYKAN JEFF | Director | Stock Award(Grant) | Sep 12, 2023 | 0 |
| JASINSKI LAWRENCE J | Chief Executive Officer | Stock Award(Grant) | Sep 12, 2023 | 0 |
| LAWLESS MICHAEL A. | Chief Financial Officer | Purchase | Aug 24, 2023 | 405,051 |
| LEVY HADAR | Director | Stock Award(Grant) | Sep 12, 2023 | 0 |
| LYNCH JEANNINE | Officer | Sale | Aug 30, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Osaic Holdings Inc | 1.65% | 981,042 | 588.63K | Jun 29, 2023 |
| Sabby Management, LLC | 0.95% | 567,394 | 340.44K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.37% | 222,500 | 133.50K | Jun 29, 2023 |
| Susquehanna International Group, LLP | 0.12% | 74,385 | 44.63K | Jun 29, 2023 |
| Millennium Management Llc | 0.07% | 42,362 | 25.42K | Jun 29, 2023 |
| Squarepoint Ops LLC | 0.07% | 42,524 | 25.51K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.05% | 29,639 | 18.08K | May 30, 2023 |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 3,262 | 1.96K | Jun 29, 2023 |